Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide. (2013)

First Author: Henry JY
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.12087

PubMed Identifier: 23374145

Publication URI: http://europepmc.org/abstract/MED/23374145

Type: Journal Article/Review

Volume: 139

Parent Publication: Immunology

Issue: 3

ISSN: 0019-2805